{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:25:18Z","timestamp":1794029118056,"version":"4.8.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.neuropharm.2026.111227","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:22:38Z","timestamp":1792020158000},"page":"111227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Deficiency of synaptotagmin 9 in the hippocampal region induces synaptic damage and cognitive impairment in Parkinson's disease mice via BDNF\/TrkB signaling"],"prefix":"10.1016","volume":"302","author":[{"given":"Ning","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yile","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanchen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9930-7333","authenticated-orcid":false,"given":"Ruth G.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111227_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archneur.60.3.387","article-title":"Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study","volume":"60","author":"Aarsland","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111227_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18368","article-title":"BDNF\/TrkB activators in Parkinson's disease: a new therapeutic strategy","volume":"28","author":"Ali","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.111227_bib3","article-title":"IC-P-142: hippocampal atrophy and lateral ventricle enlargement in parkinson's disease subjects with mild cognitive impairment","volume":"6","author":"Apostolova","year":"2010","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2026.111227_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav1483","article-title":"Synaptotagmin-3 drives AMPA receptor endocytosis, depression of synapse strength, and forgetting","volume":"363","author":"Awasthi","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.111227_bib5","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.neuron.2016.09.006","article-title":"Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline","volume":"91","author":"Ballinger","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111227_bib6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ibneur.2025.03.009","article-title":"Distribution of mRNA for the exocytotic calcium sensor, synaptotagmin 9, in mouse brain","volume":"18","author":"Boateng","year":"2025","journal-title":"IBRO Neuroscience Rep."},{"key":"10.1016\/j.neuropharm.2026.111227_bib7","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/jnnp.2003.031237","article-title":"Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment","volume":"75","author":"Bruck","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111227_bib8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2026.111227_bib9","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1523\/JNEUROSCI.4087-12.2013","article-title":"Complexin activates exocytosis of distinct secretory vesicles controlled by different synaptotagmins","volume":"33","author":"Cao","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111227_bib10","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1172\/JCI43992","article-title":"Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice","volume":"121","author":"Cazorla","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2026.111227_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54604-4","article-title":"Synaptotagmin-11 deficiency mediates schizophrenia-like behaviors in mice via dopamine over-transmission","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.111227_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41582-023-00905-z","article-title":"A multiple hits hypothesis for memory dysfunction in Parkinson disease","volume":"20","author":"Citro","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111227_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-42497-8","article-title":"Synaptotagmin-7 outperforms synaptotagmin-1 to promote the formation of large, stable fusion pores via robust membrane penetration","volume":"14","author":"Courtney","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.111227_bib14","doi-asserted-by":"crossref","first-page":"7309","DOI":"10.1523\/JNEUROSCI.1060-22.2022","article-title":"Downregulating PTBP1 fails to convert astrocytes into hippocampal neurons and to alleviate symptoms in alzheimer's mouse models","volume":"42","author":"Guo","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111227_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122358","article-title":"Molecular mechanism of cognitive impairment associated with Parkinson's disease: a stroke perspective","volume":"337","author":"Gupta","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2026.111227_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature19766","article-title":"Autocrine BDNF\u2013TrkB signalling within a single dendritic spine","volume":"538","author":"Harward","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.111227_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fnins.2018.00029","article-title":"Deep brain stimulation to alleviate freezing of gait and cognitive dysfunction in Parkinson's disease: update on Current research and future perspectives","volume":"12","author":"Huang","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111227_bib18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3390\/biomedicines10051143","article-title":"Brain-derived neurotropic factor in neurodegenerative disorders","volume":"10","author":"Ibrahim","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuropharm.2026.111227_bib19","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1474-4422(09)70293-5","article-title":"Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms","volume":"8","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2026.111227_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pnpbp.2018.07.010","article-title":"Serum level of brain-derived neurotrophic factor in Parkinson's disease: a meta-analysis","volume":"88","author":"Jiang","year":"2019","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.111227_bib21","doi-asserted-by":"crossref","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","article-title":"Generic diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2026.111227_bib22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s12276-024-01156-8","article-title":"Synaptotagmin-4 induces anhedonic responses to chronic stress via BDNF signaling in the medial prefrontal cortex","volume":"56","author":"Kim","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.111227_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","article-title":"The Y-Maze for assessment of spatial working and reference memory in mice","volume":"1916","author":"Kraeuter","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2026.111227_bib24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(18)30127-3","article-title":"Risk factors for non-motor symptoms in Parkinson's disease","volume":"17","author":"Marinus","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2026.111227_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.expneurol.2015.06.013","article-title":"Relative contributions of severe dopaminergic neuron ablation and dopamine depletion to cognitive impairment","volume":"271","author":"Morgan","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111227_bib26","article-title":"Characteristics and mechanisms of cognitive impairment in Parkinson disease","author":"Oikonomou","year":"2025","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111227_bib27","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202300291RR","article-title":"Genetic ablation of synaptotagmin-9 alters tomosyn-1 function to increase insulin secretion from pancreatic \u03b2-cells improving glucose clearance","volume":"37","author":"Rahman","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2026.111227_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9645","article-title":"Sex-specific regulation of follicle-stimulating hormone secretion by synaptotagmin 9","volume":"6","author":"Roper","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.111227_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114483","article-title":"Excessive firing of dyskinesia-associated striatal direct pathway neurons is gated by dopamine and excitatory synaptic input","volume":"43","author":"Ryan","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2026.111227_bib30","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1523\/JNEUROSCI.1857-22.2023","article-title":"Synaptotagmin 9 Modulates spontaneous neurotransmitter release in striatal neurons by regulating substance P secretion","volume":"43","author":"Seibert","year":"2023","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111227_bib31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41586-018-0666-1","article-title":"m6A facilitates hippocampus-dependent learning and memory through YTHDF1","volume":"563","author":"Shi","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.111227_bib32","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.euroneuro.2015.09.002","article-title":"Alterations in brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant effects of a TrkB agonist and antagonist","volume":"25","author":"Shirayama","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111227_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/jamaneurol.2021.4140","article-title":"Adjunctive therapies in parkinson disease\u2014have we made meaningful progress?","volume":"79","author":"Simuni","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuropharm.2026.111227_bib34","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/jnr.24854","article-title":"Cleaved PINK1 induces neuronal plasticity through PKA-mediated BDNF functional regulation","volume":"99","author":"Soman","year":"2021","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2026.111227_bib35","article-title":"BDNF-TrkB signaling in Mitochondria: implications for neurodegenerative diseases","author":"Soman","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111227_bib36","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41582-024-01034-x","article-title":"Parkinson disease therapy: current strategies and future research priorities","volume":"20","author":"Stocchi","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111227_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-63444-9","article-title":"Synaptic vesicle endocytosis deficits underlie cognitive dysfunction in mouse models of GBA-linked Parkinson's disease and dementia with lewy bodies","volume":"16","author":"Vidyadhara","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.111227_bib38","article-title":"Synaptotagmin-11 is a critical mediator of parkin-linked neurotoxicity and Parkinson's disease-like pathology","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.111227_bib40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2021.12.003","article-title":"BDNF signaling in context: from synaptic regulation to psychiatric disorders","volume":"185","author":"Wang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2026.111227_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neuint.2018.01.006","article-title":"Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T Parkinson's disease mouse model","volume":"114","author":"Wang","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2026.111227_bib41","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"Microglial Ffar4 deficiency promotes cognitive impairment in the context of metabolic syndrome","volume":"10","author":"Wang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuropharm.2026.111227_bib42","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.conb.2020.04.006","article-title":"The diversity of synaptotagmin isoforms","volume":"63","author":"Wolfes","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111227_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101567","article-title":"Fading memories in aging and neurodegeneration: is p75 neurotrophin receptor a culprit?","volume":"75","author":"Wong","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuropharm.2026.111227_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.691363","article-title":"The role of Calmodulin vs. synaptotagmin in exocytosis","volume":"14","author":"Xue","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111227_bib45","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.neuron.2024.02.017","article-title":"P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy","volume":"112","author":"Zhang","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111227_bib46","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature23484","article-title":"The primed SNARE\u2013complexin\u2013synaptotagmin complex for neuronal exocytosis","volume":"548","author":"Zhou","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.111227_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41420-025-02538-1","article-title":"TREM2 deficiency exacerbates cognitive impairment by aggravating \u03b1-Synuclein-induced lysosomal dysfunction in Parkinson's disease","volume":"11","author":"Zhu","year":"2025","journal-title":"Cell Death Discov."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826004028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826004028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:53:27Z","timestamp":1794027207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826004028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":47,"alternative-id":["S0028390826004028"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111227","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deficiency of synaptotagmin 9 in the hippocampal region induces synaptic damage and cognitive impairment in Parkinson's disease mice via BDNF\/TrkB signaling","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111227"}}